C004
אקס טי אל ביופרמסוטיקלס בע"מ
2
Public
X T L BIOPHARMACEUTICALS LTD
4312
Corporation no:
520039470
Stock Exchange/Market:
אקס טי אל
1996
352
Hasapir
3
,
Nes Ziona
76100
,
,
Tel:
08-9304444
,
Fax:
08-9304445
E.mail address:
rcohen@xtlbio.com
Date of transmission:
20/03/2006
Time of broadcast:
09:46
09:34:17
Reference:
2006-02-025294
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate report on other matter
Don't use this form if there is more adequate one
XTL BIOPHARMACEUTICALS LTD. RAISES $28 MILLION IN PRIVATE EQUITY TRANSACTION WITH INSTITUTIONAL INVESTORS
Attached file
05-06Financing2006_20Mar06_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
21/02/2006
Name of the Signatory
:
Burgin Jonathan
,
,
Position of Signatory in the reporting corporation:
Chief Financial Officer
Hasapir
Telephone:
08-9304440
,
Facsimile:
08-9300659
,
E-mail:
jburgin@xtlbio.com